An observational study in Myocarditis, sponsored by First Affiliated Hospital Xi'an Jiaotong University. Recruiting at 1 site in China. Open to participants aged 3 Years to 80 Years. Per ClinicalTrials.gov, last updated 2024-07-12.
Sponsored by First Affiliated Hospital Xi'an Jiaotong University · Observational
The aim of this study is to collect clinical data and biological specimens from patients with myocarditis and construct a predictive model for the prognosis of myocarditis.
The aim of this study is to retrospectively and prospectively collect clinical data and biological specimens from patients with myocarditis who meet the inclusion and exclusion criteria. General molecular biology analysis, genome sequencing, transcriptome sequencing, methylation sequencing, metabolomics analysis, proteomics analysis, genome-wide chromosome conformation capture and other techniques are used to construct a prognosis prediction model for myocarditis.
164 studies on the registry are indexed under Myocarditis; 71 are open to participants now.
This study's planned enrollment of 1,000 is above the median of 226 across 115 observational studies indexed under Myocarditis.
Browse Myocarditis studies →First Affiliated Hospital Xi'an Jiaotong University is the lead sponsor of 306 studies on the registry; 86 are open to participants now.
Counted across the registry records on this site, refreshed daily.
All hospitalized patients who meet the diagnostic criteria for myocarditis and undergo regular follow-up at the corresponding cardiovascular center are included in the study.
Exclusion Criteria:
All enrolled patients are administered antiviral drugs, glucocorticoids, immunoglobulins, and other standard treatments. Additionally, the decision to provide ECMO support therapy is based on the severity of the patient's condition.
Change in the incidence of MACCE
MACE (major adverse cardiovascular events) including all-cause death, myocardial infarction, stroke and coronary revascularization surgery. The MACCE will be assessed from the medical records.
Time frame: 1, 3, 6 months after enrollment; and 1, 2, 3, 4, 5 years after enrollment.
Change in the incidence of all-cause death
All-cause death diagnosed by clinical doctors will be assessed from the medical records
Time frame: 1, 3, 6 months after enrollment; and 1, 2, 3, 4, 5 years after enrollment.
Change in the incidence of myocardial infarction
Myocardial infarction diagnosed by clinical doctors will be assessed from the medical records
Time frame: 1, 3, 6 months after enrollment; and 1, 2, 3, 4, 5 years after enrollment.
Change in the incidence of stroke
Stroke diagnosed by clinical doctors will be assessed from the medical records
Time frame: 1, 3, 6 months after enrollment; and 1, 2, 3, 4, 5 years after enrollment.
Change in the incidence of coronary revascularization surgery
Coronary revascularization surgery completed by clinical doctors will be assessed from the medical records
Time frame: 1, 3, 6 months after enrollment; and 1, 2, 3, 4, 5 years after enrollment.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
First Affiliated Hospital Xi'an Jiaotong University